medvi glp-1 is showing what a new kind of company can look like A telehealth platform selling weight-loss drugs directly to consumers Built in ~2 months with ~20K Now tracking toward $1.8B MedVi: Real Costs, Facts and
Description
Some platforms advertise a low entry price and quietly increase costs at every tier

Its apocalyptic
GLP-1 (Glucagon-Like Peptide-1) GLP-1 is a hormone your body releases when you eat, especially after a meal

Tirzepatide is marketed as Zepbound for non-diabetic weight loss and Mounjaro for diabetes
